SB

Sanjeev Bhavikatti

Active Director Designated Partner DIN 08790426
DIN 08790426 First appointment Jul 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjeev Bhavikatti

Data last updated:

Sanjeev Bhavikatti is a Designated Partner at Aruk Pharma Limited Liability Partnership (since 2020). The company operates in Healthcare.

DIN 08790426
Primary Designation Designated Partner
Industry Healthcare
First Appointment 12 Jul 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Jul 20202020Active

Board colleagues of Sanjeev Bhavikatti

NameDINCompanyDesignation
Sukanya Sanjeev Bhavikatti09391785Aruk Pharma Limited Liability PartnershipDesignated Partner

Directorship timeline

Open interactive timeline →
Aruk Pharma Limited Liability Partnership
Premium access

Shareholding and investment profile for Sanjeev Bhavikatti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeev Bhavikatti

Sanjeev Bhavikatti currently holds 1 directorship: Aruk Pharma Limited Liability Partnership (Designated Partner, since 12 Jul 2020).

Sanjeev Bhavikatti was first appointed on 12 Jul 2020 as Designated Partner at Aruk Pharma Limited Liability Partnership.

The current boards of Sanjeev Bhavikatti's companies include Sukanya Sanjeev Bhavikatti (Aruk Pharma Limited Liability Partnership).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available